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of typhoid fever, the human specific pathogen (S. enterica serovar 
Typhi; S. Typhi) causes significant morbidity and mortality world-
wide (Rabsch et al., 2001; Crump and Mintz, 2010; Graham, 2010). 
Salmonella spp. have been studied quite extensively with regard 
to their pathogenic properties including their ability to penetrate 
the intestinal barrier, and for typhoidal species, to replicate within 
host macrophages. However, only recently have studies begun to 
intensify with regard to the interaction of Salmonella spp. with 
the gastrointestinal microbiota. In this review, we will summarize 
the literature with regard to the role that the microbiota plays in 
colonization resistance against Salmonella spp., how salmonellae 
are able to overcome this colonization resistance, other factors that 
influence the survival of Salmonella spp. in the gut, and the methods 
that have been used to study Salmonella–microbiota interactions 
(Figure 1).
Methods to study Salmonella spp. interactions 
with the gut Microbiota
Several methods have been developed that could be used to study 
Salmonella spp. interactions with the gastrointestinal microbial 
community. We will briefly review methods to study Salmonella 
spp. gene expression and to screen for mutant phenotypes in vivo. 
Conversely, metagenomic and next generation sequencing methods 
can be used to study the effect of Salmonella spp. on the rest of the 
microbiota or the host.
The original genetic method to study gene expression in vivo 
was called in vivo expression technology (IVET; Mahan et al., 
1993; Slauch et al., 1994). This is a promoter trapping strategy 
that can identify genes that are expressed in vivo but not in 
vitro. Essentially, a library of random purA–lacZ fusions is 
created in a purA deletion background. The purA gene is an 
essential metabolic gene so only those library members that 
contain fusions expressed in vivo can survive in the mouse. 
The survivors are recovered from the mouse and plated on 
introduction
Humans are colonized by trillions of bacteria that primarily reside 
on mucosal and epithelial surfaces (Costello et al., 2009). These 
microbes exist principally in a balanced symbiotic relationship 
with the host, thus resulting in little or no pathogenic outcome 
unless the host or the colonized mucosa becomes compromised 
(Lee and Mazmanian, 2010). The anatomic location for most of 
these microbes is the gut, which contains an estimated 10–100 tril-
lion microbes representing at least 160 bacterial species per person 
(>1000 bacterial species can be found among different humans; 
Hooper and Gordon, 2001; Eckburg et al., 2005; Turnbaugh and 
Gordon, 2009; Lee and Mazmanian, 2010; Qin et al., 2010). The 
majority of these bacteria belong to one of two major phyla: 
Firmicutes and Bacteroidetes (Ley et al., 2006, 2008). These intes-
tinal microbes provide many benefits for the host, including proper 
development of the immune system, the digestion of food and 
absorption of nutrients, the production of key vitamins (e.g., vita-
min K and biotin), and protection against invading pathogenic 
organisms (Backhed et al., 2005; Lee and Mazmanian, 2010). Such 
protection against the colonization by pathogens has been called 
colonization resistance (van der Waaij et al., 1971; Stecher et al., 
2008). In the literature, there is copious data to support the con-
tention that the normal intestinal flora, or microbiota, protects 
against these invading microbes. For example, germ-free or abi-
otic mice possess increased susceptibility to enteric pathogens as 
well as abnormal intestinal mucosal immune system development 
(Bohnhoff et al., 1954; Miller and Bohnhoff, 1963; Gustafsson, 1982; 
Que and Hentges, 1985; Nardi et al., 1989; Lee and Mazmanian, 
2010).
Salmonella species (spp.) are a significant group of intestinal 
pathogens with primary clinical manifestations of gastroenteritis 
and typhoid fever. Non-typhoidal Salmonella spp. (e.g., S. enterica 
serovar Typhimurium; S. Typhimurium) result in much of the 
food-borne disease diagnosed worldwide, while the primary cause 
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X-Gal (5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside), 
a colorimetric indicator of LacZ activity, to identify those 
fusions that are not expressed in vitro. This method was suc-
cessful in identifying numerous metabolic and virulence genes 
that are expressed in vivo (Heithoff et al., 1997). One disad-
vantage of the method is that purA is essential throughout 
infection and may be too stringent. Other variations that used 
antibiotic resistance genes in place of purA were developed so 
that a pulse of antibiotic could be administered to the mouse 
to provide shorter periods of selection (Mahan et al., 1995; 
Young and Miller, 1997).
A variation of the IVET method is RIVET (Recombination-
based IVET; Camilli et al., 1994; Camilli and Mekalanos, 1995), 
which utilizes tnpR fusions. The readout for tnpR is the site-specific 
recombination of a pair of target sites (res sites) placed elsewhere in 
the chromosome. DNA between the target sites is deleted, leaving a 
single res site. A variety of marker genes can be placed between these 
res sites. The first variant used a res-tetRA-res cassette so that the 
readout for tnpR expression is a change from tetracycline resistant 
to tetracycline sensitive. The advantage of RIVET is that the gene 
expression event is recorded permanently in the genome. RIVET has 
been used extensively to study Vibrio cholerae (Osorio et al., 2005; 
Lombardo et al., 2007). This method has also worked well for study-
ing S. Typhimurium phoPQ and pmrAB expression in the gastroin-
testinal tract and for determining that the S. Typhimurium AHL 
detector, SdiA, becomes active in Yersinia-infected mice (Merighi 
et al., 2005; Smith et al., 2008; Dyszel et al., 2010; Noel et al., 2010).
GFP is another reporter that can be used to study single genes or 
entire libraries. A method termed differential fluorescence induc-
tion (DFI) can be used to sort bacteria that have high fluorescence 
in vivo from those that have low fluorescence in vitro (Valdivia and 
Falkow, 1996, 1997; Valdivia et al., 1996; Bumann and Valdivia, 
2007). Though powerful, this method has not yet been used to 
study Salmonella spp. interactions specifically with the intestinal 
microbiota.
Phenotypic methods for studying Salmonella spp. interactions 
with the microbiota are advancing rapidly. For screening hundreds 
or thousands of Salmonella spp. mutants simultaneously there are 
now two different approaches. The first approach is to use microar-
rays to monitor the populations of individual mutants in a library, 
before and after a selective event, such as transit through an animal 
(Badarinarayana et al., 2001; Sassetti et al., 2001). All mutants that 
increase or decrease in proportion to the remainder of the library 
are readily identified. The microarray methodologies are primarily 
called transposon site hybridization (TraSH; Sassetti et al., 2001; 
Murry et al., 2008). Several TraSH variants have been successful 
in identifying Salmonella spp. genes required for host coloniza-
tion (Lawley et al., 2006; Chaudhuri et al., 2009; Santiviago et al., 
2009). The second approach uses next generation sequencing tech-
nology to measure the proportion of mutants in a library before 
and after the selective event. This method is primarily referred to 
as Tn-seq (van Opijnen et al., 2009; Opijnen and Camilli, 2010; 
Gallagher et al., 2011) or INSeq (Goodman et al., 2009). By bar-
coding each experiment, one can put up to 96 Tn-seq experiments 
Figure 1 | Salmonella spp. interaction with the intestinal microbiota. (A) The 
gut microbiota (illustrated by the multiple colored bacteria) mediates 
“colonization resistance” by outcompeting invading pathogens such as 
Salmonella. In addition, innate immune defenses (e.g., antimicrobial molecules, 
mucus, sIgA, etc.) help to prevent pathogen colonization. At the time of this 
initial interaction of Salmonella with the microbiota, signals produced by the host 
and the gut microbes are being sensed by Salmonella, which influences the 
pathogenic outcome. (B) Salmonella spp. are able to overcome colonization 
resistance and initiate localized inflammation, which is key to disease 
manifestation. This inflammation is a result of motile Salmonella and SPI-1-
mediated invasion of M-cells in Peyer’s patches and enterocytes, as well as 
PAMP signaling. Phagocytic cell uptake and subsequent host cell signaling 
results in alteration of the microbiota, further induction of host innate resistance 
mechanisms (to which the bacteria respond with their own induced resistance), 
and the increased availability of growth substrates, some which specifically 
allow Salmonella to outcompete the microbiota. Perturbation of the microflora 
(e.g., antibiotic/probiotics) also creates an altered gut environment that can 
affect Salmonella spp. colonization.
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S. Typhimurium persists in the GI tract for greater than 30 days in 
these mice and has been found to persist in the mesenteric lymph 
nodes and gallbladder as well (Monack et al., 2004; Lawley et al., 
2006; Crawford et al., 2010).
streptoMycin-treated and gnotobiotic Mice
While S. Typhimurium infection of susceptible mice has been 
used to model human typhoid fever, there are two problems with 
using conventional mice as a model for S. Typhimurium gastro-
enteritis. The first problem is that the mice do not get diarrhea 
as in the human infection. The second problem is that the nor-
mal microbiota causes bottlenecks in Salmonella spp. popula-
tions during phenotypic screening experiments. This is an issue 
for any method that requires large numbers of library members 
to undergo selection in the animal (IVET, TraSH, Tn-seq, etc.). 
Bottlenecks are the stochastic loss of library members, render-
ing the TraSH or Tn-seq results unreliable. Mice treated with 
antibiotics to disrupt their normal flora (most commonly strep-
tomycin) do not cause Salmonella spp. populations to bottleneck 
(Hapfelmeier and Hardt, 2005; Stecher and Hardt, 2011). These 
mice also get symptoms that are closer to human gastroenteritis, 
allowing this human disease to be modeled. Gnotobiotic mice 
have the same advantages as streptomycin-treated mice but have 
the additional advantage that the composition of the microbial 
community can be controlled. Gnotobiotic simply means “known 
flora” and this can range from abiotic mice that have no flora 
(also known as germ-free or axenic), to mono-associated mice 
that are colonized with a single known microbial species, to poly-
associated mice that are colonized with multiple species (Falk 
et al., 1998). The combination of gnotobiotic mice with TraSH, 
Tn-seq, and deep sequencing methods should revolutionize the 
study of how Salmonella spp. interact with the intestinal micro-
biota (Goodman et al., 2009; Faith et al., 2010).
antiMicrobial MechanisMs of the huMan gut and 
gut Microflora
The human gut contains an arsenal of barriers to incoming patho-
genic organisms. These barriers can come in many forms, including 
physical, chemical, enzymatic, or immune. Salmonella spp., which 
primarily colonize the distal ileum/cecum, first must overcome 
physical barriers in this environment. Although not always con-
sidered, a thick mucous layer covers the intestinal epithelium and 
presents a significant challenge to microbes that must traverse this 
layer to come into direct contact with the intestinal epithelium. 
Though the mucus provides an environment for attachment and 
nutrition, it both prevents epithelial cell engagement and harbors 
other antimicrobial substances such as IgA and cationic anti-
microbial peptides (CAMPs; Lievin-Le Moal and Servin, 2006; 
Macpherson and Slack, 2007; Meyer-Hoffert et al., 2008). The 
CAMPs found in the gut are primarily either defensins or catheli-
cidins (Zasloff, 2002; Iimura et al., 2005; Ouellette, 2010; Salzman 
et al., 2010). CAMPs typically kill bacteria by forming pores in 
the membrane, but these peptides have also been shown to have 
immunomodulatory activities, primarily resulting in the recruit-
ment of neutrophils to sites of infection (Yang et al., 2001; Bowdish 
et al., 2006; Hazlett and Wu, 2011). Mucins (e.g., MUC4), IgA, and 
antimicrobial peptides can be regulated by bacterial  colonization 
into a single sequencing run. This has been termed Bar-seq (Smith 
et al., 2010). Though clearly applicable and achievable, to date, 
no research groups have used any of these methods to study how 
Salmonella spp. interact specifically with other members of the 
intestinal microbiota.
Genomic DNA libraries, or cDNA libraries, of entire micro-
bial communities can be constructed and screened for the pres-
ence of individual DNA sequences of interest, or the libraries 
can be sequenced in their entirety. Alternatively, the library can 
be screened for function in a heterologous host, typically E. coli. 
This is called metagenomics and has been used to identify the 
entire “metagenome” of gut microbial communities from sev-
eral animal and human subjects (Handelsman, 2004). Newer 
deep sequencing methods are being used to sequence the entire 
gut community or “microbiome.” This is a powerful technique 
for predicting the type and abundance of microbes present as 
well as metabolic pathways and function of the community as a 
whole (Booijink et al., 2007; Frank and Pace, 2008; Ventura et al., 
2009; Qin et al., 2010; Vacharaksa and Finlay, 2010; Wang et al., 
2010). The type and quantity of community variation can be 
characterized between healthy individuals, diseased individuals, 
and individuals after perturbations such as antibiotics or changes 
in diet (Turnbaugh and Gordon, 2009; Neu et al., 2010; Willing 
et al., 2010). In addition, quantitation of 16S rDNA has been used 
to study the effects of Salmonella and other pathogens on the 
gut microbial community (Lupp et al., 2007; Stecher et al., 2007; 
Barman et al., 2008; Sekirov et al., 2010). Using this technology,  it 
was found that Salmonella-induced inflammation both decreased 
the population and altered the composition of the microbiota in a 
manner that was dependent upon Salmonella SPI1 and SPI2 and 
upon reactive oxygen and nitrogen species of the host (Stecher 
et al., 2007; Ackermann et al., 2008).
aniMal Models for studying Salmonella spp. 
interactions with the Microbiota
conventional Mice
The most commonly used animal model for S. Typhimurium 
infection is the BALB/c or C57BL/6 mouse. These mice have a 
mutation in the Slc11a1 gene (previously known as Nramp1) that 
leaves them susceptible to systemic infection by S. Typhimurium. 
The Slc11A1 mutation causes a defect in ion transport in phago-
cytic vesicles allowing S. Typhimurium to survive in macrophages 
(Blackwell et al., 2001). This model serves as a surrogate for the 
infection of humans by the host-restricted serovar Typhi that 
causes Typhoid fever, though new humanized mouse models for S. 
Typhi have recently been developed (Firoz Mian et al., 2010; Libby 
et al., 2010; Song et al., 2010). Typhimurium is an extremely impor-
tant human and animal pathogen in its own right, being one of 
the most common and most serious, causes of human food-borne 
gastroenteritis (Scallan et al., 2011). Additionally, in Africa, non-
typhoidal serovars (NTS) including Typhimurium have become a 
major cause of systemic disease in immunocompromised patients 
(Kingsley et al., 2009; Gordon et al., 2010; Graham, 2010). One 
drawback of Slc11A1 mouse strains is that they succumb to even 
low dose infection fairly rapidly, within 10 days. To study persist-
ence, some researchers are using 129/SvJ or CBA mice that bear a 
functional Slc11A1 allele (Lawley et al., 2006; Tsolis et al., 2011). 
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majority of the outer leaflet of the outer membrane of Salmonella 
spp. (Guo et al., 1997; Gunn, 2008; Richards et al., 2010). These 
modifications, mediated primarily by environmental sensing via the 
two-component regulatory systems PhoP–PhoQ and PmrA–PmrB, 
result in resistance to CAMPs either by lack of CAMP binding 
to the bacterium or poor penetration of the CAMPs to the inner 
membrane, the site of lethal action (Guo et al., 1998; Richards 
et al., 2010). Thus, it can be hypothesized that upon Salmonella 
spp. entry into the intestinal environment and subsequent CAMP 
induction (CAMPs can activate the PhoP–PhoQ and PmrA–PmrB 
regulatory systems), these CAMPs may differentially affect the 
microbiota (reduce it) while allowing CAMP resistant Salmonella 
spp. to flourish.
inflaMMation as a MechanisM to overcoMe gut 
colonization resistance
While the human intestine is always in a mild state of inflammation, 
invading pathogens trigger an induction of innate and adaptive 
immune responses. The inflammatory response of the host is trig-
gered by effector molecules secreted by Type III secretion systems 
of Salmonella pathogenicity Islands I and II as well as extracellular 
and intracellular detection of pathogen associated molecular pat-
terns (PAMPS) of the bacteria, which include LPS, peptidoglycan, 
and flagellin (Zhou and Galan, 2001; Abrahams and Hensel, 2006). 
LPS is detected through the combinatorial efforts of LPS-binding 
protein, CD14, MD-2, and toll-like receptor (TLR)-4 (Abreu, 2010). 
Peptidoglycan is detected by TLR-2 as well and intracellularly by 
proteins of the nucleotide-binding and oligomerization domain 
(NOD)-like receptors (NLRs; Abreu, 2010). Flagellin is detected 
by TLR-5 as well as NLRP3 (NLR family pyrin domain contain-
ing; previously NALP3) and NLRC4 (NLR family CARD domain 
containing; previously IPAF [IL-1β-converting enzyme protease 
activating factor]), both of which activate caspase-1 in response to S. 
Typhimurium (Grassl and Finlay, 2008; Broz et al., 2010). Such NLR 
signaling induces the expression of proinflammatory cytokines 
such as IL-1β and IL-18 (Tam et al., 2008). These cytokines, along 
with IL-23, result in an immune cascade of activation involving 
T-cell induced IL-17 and IFN-γ, ultimately resulting in the induc-
tion of host-derived intestinal defense mechanisms discussed earlier 
(Stecher et al., 2007; Santos et al., 2009).
Salmonella Typhimurium has been shown to be unable to colo-
nize the mouse intestine in the absence of inflammation, as the 
normal flora in the non-inflamed state is able to effectively out-
compete an avirulent (lacking inflammatory capacity) Salmonella 
intruder (Stecher et al., 2007; Santos et al., 2009; Winter et al., 2010). 
This phenomenon can be reversed by either mixing the avirulent 
S. Typhimurium with wildtype strains capable of inducing inflam-
mation or in mice lacking the anti-inflammatory cytokine IL-10. 
Additionally, Salmonella-induced inflammation results in an altered 
microbiota, which may also favor growth of the pathogen (Lupp 
et al., 2007; Barman et al., 2008).
the link between the host, Microbial MetabolisM, 
and Salmonella spp. intestinal colonization
As discussed above, nutrient availability can be increased upon 
Salmonella spp. induction of inflammation. Also discussed 
above, SCFA synthesis by the microbiota can be used both by 
and thus represent an inducible mechanism of resistance (Salzman 
et al., 2003; Macpherson and Uhr, 2004; Raffatellu et al., 2009; 
Veldhuizen et al., 2009).
As well as traversing the mucous layer, colonizing pathogenic 
microbes must compete effectively with the existing microbiota. 
This microbiota provides a crucial line of defense as they can both 
compete for nutritional resources and for attachment sites to the 
intestinal epithelium. In addition, some microflora can produce 
bacteriocins, which are toxins that act in a similar manner to 
CAMPs but are produced by the microbiota instead of the host 
(Sanchez et al., 2010). If invading microbes are able to overcome 
the mucous layer and compete effectively against the microflora, 
other antimicrobial molecules must also be successfully overcome. 
Interleukin signaling from the mucosa results in the host production 
of lipocalin-2, which binds to the siderophore enterobactin/entero-
chelin in an attempt to withhold iron from bacteria (Raffatellu et al., 
2009; Blaschitz and Raffatellu, 2010; Raffatellu and Bäumler, 2010). 
However, Salmonella also produces a second siderophore, salmo-
chelin, which is not bound by lipocalin-2, thus enabling Salmonella 
spp. to compete for iron necessary for growth (Raffatellu et al., 
2009). The Paneth cells found at the base of the intestinal crypts 
produce, in addition to the aforementioned CAMPs, antimicro-
bial products including angiogenins and the C-type lectin, RegIIIγ 
(regenerating gene; mouse)/HIP-PAP (hepatocarcinoma-intestine-
pancreas/pancreas-associated protein; Human); Hooper et al., 
2003; Cash et al., 2006). Although RegIIIγ is induced by mucosal 
damage and inflammatory stimuli, it is primarily effective against 
Gram-positive bacteria and thus would play a limited direct role 
against Salmonella spp. (Brandl et al., 2008; Godinez et al., 2009; 
Lehotzky et al., 2010).
The intestinal microbes themselves, in addition to producing 
bacteriocins, produce short chain fatty acids (SCFAs) as a conse-
quence of their metabolic activity (Cummings and Macfarlane, 
1991, 1997). Microbiota-produced butyrate and acetate can have 
dramatic effects on both the host and on Salmonella spp. during 
infection (Garner et al., 2009). Acetate and formate in the small intes-
tine were found to have a positive effect on Salmonella Pathogenicity 
Island I-mediated invasion (Huang et al., 2008; Chavez et al., 2010) 
while propionate and butyrate, present in high concentrations in 
the cecum and colon, had the opposite effect (Gantois et al., 2006; 
Wong et al., 2006). These metabolic byproducts thus may represent 
environmental signals that direct Salmonella spp. to the distal ileum 
for invasion. Additionally, butyrate is known to induce expression 
of the human cathelicidin LL-37 (mouse: CRAMP), which could 
clearly affect invading pathogens (Raqib et al., 2006).
Given the antimicrobial environment of the human gut, how 
can pathogens such as Salmonella spp. overcome the intestinal flora 
and antimicrobial onslaught? It is likely a multifactorial response, 
both inherent and induced. Salmonella spp. have evolved numer-
ous countermeasures to the antimicrobials present in the gut. Such 
mechanisms include resistance to both oxidative and non-oxida-
tive host killing. Resistance to reactive oxygen and nitrogen com-
pounds include such enzymes as superoxide dismutase and catalase 
(Vazquez-Torres and Fang, 2001; Prost et al., 2007; Ackermann 
et al., 2008; Kim et al., 2010). A well-studied resistance mechanism 
to non-oxidative killing includes the in vivo regulated modifica-
tions of lipopolysaccharide (LPS), a glycolipid that constitutes the 
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was recently demonstrated that growth and dissemination of S. 
Typhimurium DT104 during antibiotic (fosfomycin) treatment 
could be abrogated by continuous feeding of some, but not all, 
Lactobacillus species (a probiotic approach; Asahara et al., 2011). 
This protective capacity was found to be associated primarily 
with increased organic acid production and maintenance of a 
decreased intestinal pH. Thus, alteration of the microbiota by 
the administration of antibiotics or probiotics can have dramatic 
effects on Salmonella-associated disease.
Salmonella spp. can detect other Microbes to 
affect pathogenesis
Salmonella Typhimurium has the ability to detect the N-acyl-l-
homoserine lactone (AHL) signaling molecules of other microbes 
using SdiA, a LuxR homolog (Michael et al., 2001; Smith and 
Ahmer, 2003; Soares and Ahmer, 2011). Salmonella spp. can-
not synthesize AHLs so this system is exclusively for detecting 
other microbes. Surprisingly, AHLs have not been found in the 
GI tract of healthy mammals, with the exception of the bovine 
rumen (Erickson et al., 2002; Smith et al., 2008; Edrington et al., 
2009; Hughes et al., 2010). However, SdiA activity was detected 
in turtles colonized by Aeromonas hydrophila and in mice colo-
nized by Yersinia enterocolitica (Smith et al., 2008; Dyszel et al., 
2010). Both of these organisms are AHL-producing pathogens. In 
Yersinia-infected mice, the SdiA activity was primarily observed 
in the Peyer’s patches (Dyszel et al., 2010). In competition with 
wildtype, an sdiA mutant had no apparent fitness defect, but this 
may have been due to the small percentage of S. Typhimurium 
detecting AHLs at any given time. When S. Typhimurium was 
engineered to produce AHLs, the wildtype was much more fit 
than the sdiA mutant. All members of the SdiA regulon were 
required for the fitness phenotype indicating that all of the regu-
lon members are functional in mice (Dyszel et al., 2010). To 
date, the SdiA regulon consists of only two loci the rck operon, 
which contains six genes, and srgE (Ahmer et al., 1998; Smith and 
Ahmer, 2003). Rck is an outer membrane protein that confers 
resistance to complement killing, adhesion, and invasion of host 
cells (Ho et al., 2010; Rosselin et al., 2010). The SrgE protein is 
predicted to be a T3SS secreted effector protein with a coiled-coil 
domain (Samudrala et al., 2009). Why these genes are important 
to Salmonella spp. in the presence of AHLs is not known. It is 
also not known if this system is used to detect a specific AHL-
producing pathogen, such as Y. enterocolitica, in a specific host, 
or if the system is more general and fitness benefits are achieved 
from detecting any of a number of AHL-producing pathogens 
in a variety of hosts.
As described above, the normal microbiota produces high con-
centrations of SCFAs as a byproduct of metabolism (Cummings 
et al., 1987). These SCFAs are a significant nutrient source for the 
host and other members of the microbiota and S. Typhimurium 
regulates virulence genes in response to these SCFAs (Lawhon 
et al., 2002; Huang et al., 2008; Sartor, 2008). It appears that the 
two-component regulatory system SirA/BarA may be responsible 
for the detection of SCFAs (Chavez et al., 2010). BarA is a his-
tidine sensor kinase that phosphorylates the response regulator 
SirA (Pernestig et al., 2001). SirA then regulates the transcrip-
tion of two small RNAs that function to bind and prevent the 
the host to induce defense mechanisms and by the bacterium to 
enhance invasion of the intestinal epithelium. Recently, direct 
links have arisen between S. Typhimurium, intestinal inflamma-
tion, and metabolic properties. Winter et al. (2010) demonstrated 
that reactive oxygen species released as a result of Salmonella-
induced inflammation react with luminal thiosulfate to produce 
tetrathionate. Tetrathionate can then be used as a terminal elec-
tron acceptor for Salmonella spp. respiration, allowing for more 
efficient energy production relative to competing, fermenting 
microflora. Tetrathionate has been used since the early 1920s 
as an enrichment for Salmonella spp. in mixed microbial sam-
ples. Thus, the ability to overcome colonization resistance may 
reside in its ability to utilize inflammation-induced compounds 
to enhance growth.
In a similar vein, inflammation also releases or induces the 
expression of high-energy nutrients such as mucin and galactose-
containing molecules found in the cecum and elsewhere in the gut 
(Stecher et al., 2008). It was shown that S. Typhimurium flagellar 
and chemotaxis mutants had reduced fitness in the inflamed but 
not the non-inflamed gut. It was reasoned that motility and the 
ability to chemotax allowed S. Typhimurium to utilize specific car-
bohydrates to both help continue the inflammation and to outgrow 
the microbiota. Thus, inflammation can result in the release of 
carbohydrates, which Salmonella spp. can use to aid growth if it 
possesses intact chemotactic and motility properties.
In a move away from the gut bacterial metabolic capabili-
ties, a recent study has looked at host metabolic changes during 
Salmonella spp. intestinal infection (Antunes et al., 2011). Using 
sophisticated mass spectrometry methods, they determined that 
numerous metabolic pathways were affected, most prominently 
hormonal pathways such as those affecting steroid and eicosanoid 
synthesis. Such hormonal pathways have dramatic effects on the 
host, including wound healing, sugar metabolism, and immune 
system regulation. It is likely that some of these changes are a direct 
result of Salmonella-induced inflammation while others may be a 
result of the altered microbiota.
antibiotics, norMal flora, and Salmonella spp. 
infection
Antibiotics target certain classes of microbes, with many antibi-
otics having dramatic effects on the intestinal microbiota after 
administration to a host. Several studies (examples outlined 
below) have been completed examining the effect of antibiot-
ics on the intestinal flora, and the effect that this flora disrup-
tion has on Salmonella spp. colonization and disease as well as 
the host intestinal metabolome (Antunes et al., 2011). Recently, 
clinically relevant doses of antibiotics were shown to affect the 
ratio of microbial phyla in the intestine but not the overall bac-
terial load (Lupp et al., 2007; Sekirov et al., 2008). Other stud-
ies have found that different antibiotics have variable effects 
on the total number and distribution of gut bacteria, but that 
each antibiotic tested enhanced Salmonella-induced epithelial 
cell invasion and inflammation (Croswell et al., 2009). After 
antibiotic removal and some recovery of the microbiota, mice 
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